Skip to content
10-Q

Quarterly Report

RUBIUS THERAPEUTICS, INC.

0001709401-22-000019

← back to feed
Filed
Nov 9, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 31, 2022 90.37M sh
Shares Diluted Q3 2022 · Sep 30, 2022 90.36M sh
Shares Diluted Q3 2022 · Sep 30, 2022 90.26M sh
Shares Diluted Q3 2022 · Sep 30, 2021 89.81M sh
Shares Diluted Q3 2022 · Sep 30, 2021 87.24M sh
Capex Q3 2022 · Sep 30, 2022 $5.04M
Capex Q3 2022 · Sep 30, 2021 $2.28M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$117.63M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$107.91M
Long Term Debt Q3 2022 · Sep 30, 2022 $76.83M
Long Term Debt Q3 2022 · Dec 31, 2021 $76.15M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $103.88M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $225.85M
Stockholders Equity Q3 2022 · Sep 30, 2022 $36.59M
Stockholders Equity Q3 2022 · Jun 30, 2022 $95.54M
Stockholders Equity Q3 2022 · Mar 31, 2022 $134.65M
Stockholders Equity Q3 2022 · Dec 31, 2021 $178.78M
Stockholders Equity Q3 2022 · Sep 30, 2021 $224.21M
Stockholders Equity Q3 2022 · Jun 30, 2021 $264.11M
Stockholders Equity Q3 2022 · Mar 31, 2021 $300.98M
Stockholders Equity Q3 2022 · Dec 31, 2020 $141.56M
Current Liabilities Q3 2022 · Sep 30, 2022 $32.62M
Current Liabilities Q3 2022 · Dec 31, 2021 $34.66M
Total Liabilities Q3 2022 · Sep 30, 2022 $134.11M
Total Liabilities Q3 2022 · Dec 31, 2021 $139.24M
Current Assets Q3 2022 · Sep 30, 2022 $110.82M
Current Assets Q3 2022 · Dec 31, 2021 $229.82M
Total Assets Q3 2022 · Sep 30, 2022 $170.7M
Total Assets Q3 2022 · Dec 31, 2021 $318.02M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.70
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.77
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.55
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.62
Eps Basic Q3 2022 · Sep 30, 2022 −$0.70
Eps Basic Q3 2022 · Sep 30, 2022 −$1.77
Eps Basic Q3 2022 · Sep 30, 2021 −$0.55
Eps Basic Q3 2022 · Sep 30, 2021 −$1.62
Sga Expense Q3 2022 · Sep 30, 2022 $7.3M
Sga Expense Q3 2022 · Sep 30, 2022 $29.77M
Sga Expense Q3 2022 · Sep 30, 2021 $12.04M
Sga Expense Q3 2022 · Sep 30, 2021 $39.13M
Rd Expense Q3 2022 · Sep 30, 2022 $24.23M
Rd Expense Q3 2022 · Sep 30, 2022 $95.53M
Rd Expense Q3 2022 · Sep 30, 2021 $38.01M
Rd Expense Q3 2022 · Sep 30, 2021 $101.76M
Net Income Q3 2022 · Sep 30, 2022 −$62.87M
Net Income Q3 2022 · Sep 30, 2022 −$159.53M
Net Income Q3 2022 · Jun 30, 2022 −$44.24M
Net Income Q3 2022 · Mar 31, 2022 −$52.41M
Net Income Q3 2022 · Sep 30, 2021 −$49.02M
Net Income Q3 2022 · Sep 30, 2021 −$141.53M
Net Income Q3 2022 · Jun 30, 2021 −$50.18M
Net Income Q3 2022 · Mar 31, 2021 −$42.33M
Operating Income Q3 2022 · Sep 30, 2022 −$61.58M
Operating Income Q3 2022 · Sep 30, 2022 −$155.35M
Operating Income Q3 2022 · Sep 30, 2021 −$50.05M
Operating Income Q3 2022 · Sep 30, 2021 −$140.89M
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2021 $0
Revenue Q3 2022 · Sep 30, 2021 $0